Use These Antibiotics for Close Contacts of Invasive Meningococcal Disease, CDC Says
(MedPage Today) -- Rifampin, ceftriaxone, or azithromycin are recommended as first-line alternatives to ciprofloxacin prophylaxis for close contacts of people with meningococcal disease in areas where the disease is highly resistant to ciprofloxacin... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 10, 2024 Category: American Health Source Type: news

Ceftriaxone Prevents Ventilator-Associated Pneumonia After Brain Injury
(MedPage Today) -- PHOENIX -- Administering ceftriaxone prophylactically in the intensive care unit (ICU) reduced the risk of ventilator-associated pneumonia (VAP) among patients with an acute brain injury, a randomized double-blind trial conducted... (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - January 22, 2024 Category: Infectious Diseases Source Type: news

Vaccination Is the Best Bet Against Drug-Resistant Superbugs — Experts
Experts encourage parents to vaccinate their children against typhoid to ensure that the child has access to clean drinking water. Credit: Zofeen Ebrahim/IPS By Zofeen EbrahimKARACHI, Jul 6 2023 (IPS) The first thing you notice about eight-month-old Manahil Zeeshan is how tiny she looks on the adult-size hospital bed at the government-run Sindh Institute of Child Health and Neonatology (SICHN) in Korangi, a neighbourhood in Karachi. Her right foot is taped with a cannula, and she whimpers incessantly. “I have been in and out of the hospital for the last seven days,” said Uzma Mohammad, Zeeshan’s mom, with worry lines...
Source: IPS Inter Press Service - Health - July 6, 2023 Category: International Medicine & Public Health Authors: Zofeen Ebrahim Tags: Africa Civil Society Development & Aid Editors' Choice Featured Headlines Health Humanitarian Emergencies Inequality Poverty & SDGs TerraViva United Nations IPS UN Bureau IPS UN Bureau Report Pakistan Source Type: news

Roche announces donation of essential medicines and diagnostic solutions to the people affected by the devastating earthquake in T ürkiye and Syria
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced a donation to Türkiye and Syria with a total value of 1.5 million Swiss Francs. This includes medicines, other products and financial support. Among others, we are committed to donating 120,000 packages of Rocephin, a critical antibiotic used to treat the symptoms of many kinds of bacterial infections and listed on the World Health Organization's list of essential medicines. (Source: World Pharma News)
Source: World Pharma News - February 15, 2023 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news

Roche announces donation of essential medicines and diagnostic solutions to the people affected by the devastating earthquake in T ürkiye and Syria
Basel, 9 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced a donation to T ürkiye and Syria with a total value of 1.5 million Swiss Francs. This includes medicines, other products and financial support. Among others, we are committed to donating 120,000 packages of Rocephin, a critical antibiotic used to treat the symptoms of many kinds of bacterial infections and listed on the World Health Organization’s list of essential medicines. In addition we are committed to donating much needed supplies for diabetes management.Roche is deeply saddened by the devastating earthquake in T ürkiye and Syria on Febru...
Source: Roche Media News - February 9, 2023 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLunsumio (follicular lymp...
Source: Roche Investor Update - February 2, 2023 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Basel, 2 February 2023Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLun...
Source: Roche Media News - February 2, 2023 Category: Pharmaceuticals Source Type: news

Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trial
This study evaluates the feasibility, safety and efficacy of its clinical implementation. Methods: In this two-centre randomised clinical trial, critically ill patients with sepsis or septic shock were randomised to AutoKinetics dosing or standard dosing for four antibiotics: vancomycin, ciprofloxacin, meropenem, and ceftriaxone. Adult patients with a confirmed or suspected infection and either lactate> 2 mmol/L or vasopressor requirement were eligible for inclusion. The primary outcome was pharmacokinetic target attainment in the first 24 h after randomisation. Clinical endpoints included mortality, ICU length of stay an...
Source: Current Awareness Service for Health (CASH) - September 8, 2022 Category: Consumer Health News Source Type: news

Roche announces donation of essential medicines to Ukraine
Basel, 02 March 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced an initial donation of essential medicines to Ukraine. Roche vehemently condemns the violent invasion of the country.Roche is working diligently to support the country and people of Ukraine with medical products in accordance with Roche ’s overall mission and announced today that we are donating 150,000 packages of Rocephin, a critical antibiotic used to treat the symptoms of many kinds of bacterial infections and listed on the World Health Organization’s list of essential medicines.These donations will be delivered to Ukraine as soon as possible...
Source: Roche Media News - March 2, 2022 Category: Pharmaceuticals Source Type: news

Roche announces donation of essential medicines to Ukraine
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced an initial donation of essential medicines to Ukraine. Roche vehemently condemns the violent invasion of the country. Roche is working diligently to support the country and people of Ukraine with medical products in accordance with Roche's overall mission and announced today that we are donating 150,000 packages of Rocephin, a critical antibiotic used to treat the symptoms of many kinds of bacterial infections and listed on the World Health Organization's list of essential medicines. (Source: World Pharma News)
Source: World Pharma News - March 2, 2022 Category: Pharmaceuticals Tags: Featured Roche Business and Industry Source Type: news

ceftriaxone
Title: ceftriaxoneCategory: MedicationsCreated: 2/22/2022 12:00:00 AMLast Editorial Review: 2/22/2022 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - February 22, 2022 Category: Drugs & Pharmacology Source Type: news

Super-gonorrhoea is back: Health chiefs spot another three cases of antibiotic-resistant STI
In one case from London, an unidentified woman in her 20s was found to be infected with a strain resistant to ceftriaxone - the main antibiotic used to treat the disease. (Source: the Mail online | Health)
Source: the Mail online | Health - February 7, 2022 Category: Consumer Health News Source Type: news

Community-Onset, Ceftriaxone-Resistant Enterobacteriaceae Community-Onset, Ceftriaxone-Resistant Enterobacteriaceae
Could certain factors contribute to the likelihood of community-onset, ceftriaxone resistant Enterobacteriaceae infections? An epidemiologic analysis provides insight.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 7, 2021 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

What to D.O.: CDC Doubles Dose of Ceftriaxone for Gonorrhea
No abstract available (Source: Emergency Medicine News)
Source: Emergency Medicine News - March 1, 2021 Category: Emergency Medicine Tags: What to D.O. Source Type: news

Single-Drug Regimen Now Advised for Uncomplicated Gonorrhea
TUESDAY, Jan. 5, 2021 -- A single 500-mg intramuscular dose of ceftriaxone is recommended for treatment of uncomplicated urogenital, anorectal, and pharyngeal gonorrhea, according to updated guidelines published in the Dec. 18 issue of the U.S.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 5, 2021 Category: Pharmaceuticals Source Type: news